Byrne Asset Management’s Sanofi SNY Stock Holding History

Byrne Asset Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-65	Closed	-$3K	–	537
2022 Q2	$3K	Buy	+65	New	+$3.45K	﹤0.01%	478

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Byrne Asset Management's SNY Position: Q3 2022 in Review

Byrne Asset Management sold out of Sanofi (SNY) in Q3 2022, closing a stake of 65 shares — an estimated $3K sold.

Byrne Asset Management first reported a position in SNY in Q2 2022 and held it in 1 quarter. The position peaked at $3K in Q2 2022. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

Byrne Asset Management reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
Byrne Asset Management sold 65 Sanofi shares in Q3 2022, an estimated $3K.
Byrne Asset Management first reported a position in Sanofi in Q2 2022 and held it in 1 quarter.
Byrne Asset Management's Sanofi position peaked at $3K in Q2 2022.
587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Byrne Asset Management's 13F filing for Q3 2022, filed 19 Oct 2022.